The Hang Seng Index has reached 26,000 points, marking a 4-year high.
$TENCENT(00700)$ closed at HK$633, hitting a 3-year high, while $NetEase(NTES)$ climbed to $145, a record high.
Boosted by the rise of AI large models, the gaming industry is being revalued. With cost reduction and efficiency gains, future games are expected to become more sophisticated—and even more effective at driving in-game spending.
Among Hang Seng Index constituents:
$XIAOMI-W(01810)$ is up 62.90%, $CHINA LIFE(02628)$ is up 58.79%, $TENCENT(00700)$ is up 51.67%, $HSBC Holdings PLC(HSBC)$ is up 41.67%
Notable gainers include: $POP MART(09992)$ , up 222.80%, $SINO BIOPHARM(01177)$ , up 178%, $CHOW TAI FOOK(01929)$ , up 146.39%
So far this year, 11 Hang Seng Index constituents have doubled in value.
With global markets hitting new highs, while China markets - HK stock and A- shares - still not reclaim previous highs.
Are they still undervalued?
Are you bullish on gaming industry?
Leave your comments to win tiger coins~
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Isleigh·09-10TOPThe Hang Seng Index (HSI) crossing 26,000 marks more than a technical breakout—it reflects a shift in global capital back into Asia amid Fed policy uncertainty. While the rally is promising, it’s not broad-based and favors sectors aligned with Beijing’s priorities like AI, consumer recovery, and insurance. Beyond Tencent and Alibaba, I’m watching Xiaomi for its AI hardware pivot, Sino Biopharm for value and policy support, Chow Tai Fook as a consumer sentiment proxy, China Life for demographic and policy tailwinds, and Pop Mart for niche retail growth. My focus is on post-breakout consolidation, strong fundamentals, and alignment with China’s 5-year plan. I’m staying clear of overhyped EV names and zombie SOEs. This is a stock picker’s market. I'm not a financial advisor. Trade wisely, Comrades! @isleighLikeReport